Covid-19 has truly impacted the world and many levels. This virus came with force and created havoc all over. It does not have a preference for gender, race, or age, but it sure holds more danger to those with a compromised immune system. That is why it is so important to look into ways to protect the vulnerable ones even more.
This brings us to those suffering from diabetes. Research on Covid-19 is non-stop and new evidence suggests that some people might develop diabetes when they contract Covid-19. Even if they never had diabetes before. It seems this is possible when a person has a severe Covid-19 infection.
There are many unanswered questions when it comes to this novel virus. So much has to be studied yet about the interaction of the virus and the risk it has for diseases like diabetes and other immune-related illnesses. In these studies, the focus is also directed to the potential efficacy of medical cannabis in the treatment of diabetes.
The medical community is pushing hard for the investigation of the therapeutic properties and benefits of cannabis and its synthetic counterparts to combat the effect of the coronavirus in this current worldwide health crisis.
What do the studies find?
Research on the effect of cannabis on diabetes is not new. It is already established that there is a decreased prevalence of diabetes under those using cannabis. There are also lower insulin levels found under those who participated in medical studies. Now, with the Covid-19 crisis at hand, it seems that when severe Covid-19 is contracted, it could develop diabetes as well. In order to deal with this, researchers have set up a registry to report the cases and study the link between Covid-19 and diabetes. They also are looking into how cannabis could influence a positive outcome.
Diabetes by itself is already a prevalent crisis worldwide. Now it is of imminence importance to study the consequences of the clash between the two pandemics and to find effective ways to treat it.
What does it mean?
One study in 2019, published in the American Journal of Medicine, published that there was a link found between moderate blood sugar levels, waist size, and body mass index scores. The study uses information based on data from the National Health and Nutrition Examination Survey. In another study done at the Harvard TH Chan School of Public Health, the relationship between cannabis use and fasting insulin, glucose, and insulin resistance was also investigated.
Dr. Mittleman, responsible for the study, said that the mechanisms at work showed a possible correlation between the past use of cannabis and its resulting diabetics changes, but it still was not entirely clear how it works.
Research show now how diabetes can increase the risk of Covid-19, but there is another risk too. It seems that people may be able to develop diabetes when the body’s ability to regulate blood glucose levels breaks down. This could be due when beta cells are damaged in the pancreas where the main function is to produce the insulin hormone, resulting in type 1 diabetes. It could also happen when the body becomes insensitive to the insulin hormone, leading to type 2 diabetes.
In separate research during this pandemic period, another link was found. A panel of 17 global diabetes specialists said that there is a two-way relationship between Covid-19 and diabetes.
What Cannabis Does for Diabetes
Diabetes, both type 1 and type 2, are both a major issue around the world. It falls under the umbrella of metabolic diseases. It is characterized by high blood sugar levels due to the fact that the body either does not produce enough insulin or does not respond to insulin. It is seen as a chronic disease, but there are ways to treat the disease and therefore keep it under control.
The components of the cannabis plant have many medical benefits and are believed to also impact diabetes in a positive way. There are certain benefits of cannabis that have specific positive results for those suffering from diabetes. They are:
It stabilizes blood sugar
It lowers blood pressure
It decreases artery inflammation
It improves blood circulation
It reduces neuropathic pain
The above-mentioned benefits are all beneficial to the complications of diabetes. When a person has type 2 diabetes, people are not able to effectively use insulin. Cannabis has the ability to lower levels of insulin resistance and lower fasting blood sugar levels.
In studies done on animals, it was also found that cannabis protects against diabetic retinopathy, a condition where diabetic people can lose their sight.
One of the main contributions of medical marijuana on diabetes is that it fights inflammation. Inflammation is linked to many other chronic diseases as well. Using cannabis during this Covid-19 pandemic time, could have positive results. We still have to understand the link between how cannabis can help diabetes during this time but previous studies already indicate a positive outcome.
CANNABIS AND DIABETES, READ MORE…
Cannabis and the 2020 Election
Next month, five states will be voting on seven ballot measures to legalize cannabis. A variety of proposals, including constitutional amendments, statutory initiatives, and alternative measures, could establish new medical cannabis markets in two states and expand legalization to include adult use legalization in four states. Three of these proposals would enshrine cannabis possession and consumption within state constitutions.
This article will explore the proposals themselves as well as the short-term implications of legalization on existing license holders and the industry.
Arizona voters have another opportunity to legalize cannabis next month, after narrowly defeating adult use legislation four years ago. In recent years, the Copper State’s medical cannabis market has seen significant MSO expansion, and new mandatory testing requirements launch at the beginning of November.
There are roughly 150 medical cannabis licenses in the state currently — all of which would receive priority status in the application process for adult use licensing. Additionally, diversity applicants and applicants in areas currently lacking cannabis retail access would be fast-tracked applicants.
Prop. 207 does include local control and opt-out provisions, and a new 16% tax would direct revenue to a variety of funds, while retail operators would be able to launch delivery services as soon as 2023.
Mississippi could become the 34th state to legalize cannabis for medical use, but two competing measures are creating complications on the ballot. A citizen-driven campaign led to the placement of Initiative 65, while the legislature responded with Alternative Initiative 65A.
Initiative 65 establishes a medical cannabis program similar to the program structure of many other states; with clearly defined qualifying conditions, possession limits, taxes, registration fees, and a regulator — the state health department. The alternative includes no definitions and only allows smokable cannabis products for terminally ill patients, leaving a highly restrictive market requiring enabling legislation.
Previous bills have been proposed, but never brought to a vote — leaving some skeptical that anything at all may come of Initiative 65A.
Montana’s existing medical cannabis program relies on a system of caregivers who cultivate cannabis and make manufactured products, including edibles and concentrates. Additionally, there is a limited number of licensed dispensaries throughout the state. Legalization would be a major evolution for Montana, which has seen multiple ballot initiatives and legislative interventions in recent years.
Two measures have been placed: one constitutional amendment to set the age of 21 as the minimum buying age and a measure to establish a commercial adult use market. While no early sales provisions are included, Montana companies would be the only businesses able to start sales for the first year after legalization.
New Jersey voters may make history, legalizing the adult use of cannabis and triggering a race among Mid-Atlantic states to implement sales first. While all of New Jersey’s neighbors have existing medical cannabis programs, none have taken steps to expand further. In recent years, numerous regional state legislatures have attempted to legalize, and Public Question 1 may tip the scales for an entire region with over 50 million residents.
The text of the amendment is brief, but it establishes a definition for ‘cannabis’ while permitting possession, use, and industry operations for adults ages 21 and up. The existing Cannabis Regulatory Commission would be tasked with regulating the industry, but the state legislature must first come to an agreement and pass enabling legislation.
Currently, New Jersey’s medical market includes roughly fifteen licenses, including cultivation and manufacturing, as well as a limited number of dispensaries. The next phase for cannabis in NJ is uncharted territory for now: it is unclear if existing licenses will be given the first opportunity to serve the general public.
Given licensing delays and a slow rollout in Illinois, lawsuits and delays could be in New Jersey’s future — with some analysts suggesting a four-year timeline from amendment passage to full implementation. This may be good news for MSOs, including Columbia Care, Verano, and Acreage Holdings, among others.
South Dakota has long been unfriendly to cannabis in all forms and has some of the nation’s strictest marijuana possession penalties. While other non-medical states have at least given a nod to low-THC medical hemp programs, the Mount Rushmore state hadn’t established any kind of hemp or cannabis program at all until the legislature passed industrial hemp legalization this past spring.
Now, the state could make history as the first to legalize cannabis for medical and adult use purposes at the same time. Two proposals are on the ballot: an initiated measure to launch a medical cannabis program, and a constitutional amendment to fully legalize cannabis, with provisions including adult use, a medical program, and expanded hemp legalization.
Medical use is enshrined in both proposals, while the constitutional amendment would prevent the legislature from any type of statutory tampering to limit a retail market. The constitutional amendment would establish a commercial market for both adult use and medical purposes. Medical use would include home cultivation. As there is no cannabis market in the state at this time, no businesses would be able to take advantage of “early sales” provisions, as seen in other states.
Previously, medical cannabis programs and commercial licensing schemes predated adult use legalization, and the majority of these proposals came into existence by way of the ballot. In most of the earliest states to fully legalize, this was the case: Colorado, Washington, Alaska, Oregon, California, Massachusetts, and Nevada all had some form of voter-approved medical cannabis legislation first.
Implementation of adult-use legalization has, however, varied across the states. In these proposals, Arizona, Montana, and New Jersey have existing medical cannabis infrastructures, but the implementation of adult use will likely lead to program changes.
Some legalization measures have allowed for existing medical dispensaries to launch sales to adults during a period of late-stage rulemaking. These businesses have operated under modified compliance rules, with track-and-trace requirements and varying tax rates until legalization rules are completed.
After Oregon voters approved legalization in 2014, the state’s medical market rapidly expanded with early sales on the horizon. At one point, there were more medical dispensaries in the state than Starbucks or McDonald’s locations. That number later dropped as businesses converted their licenses over.
For some of the states with legalization on the ballot this year, the transition out of medical will pose challenges: product shortages, long customer lines, new tax rates, uncertainty over product offerings, and testing requirements on top of an already difficult pandemic business environment.
Overall, legalization measures promise to bring a significant impact to consumers and patients in Arizona, Mississippi, Montana, New Jersey, and South Dakota. It’s hard to quantify the short-term improvements to consumers and industry operators, as passage of these initiatives will set off a flurry of legislative and regulatory discussion over the holidays and into the spring. Existing licensees and hopeful applicants should keep an eye for new opportunities: public comment periods, application deadlines, and new sales opportunities on the horizon.
Jason Kikel is a Senior Data Analyst at Cannabiz Media, where he researches licenses across the cannabis marketplace and the policies behind them. He brings forth a variety of experience in urban planning, agriculture, and education, as well as enthusiasm for an expanding industry. Jason graduated magna cum laude from West Virginia University and recently completed his Master of Community + Regional Planning at The University of New Mexico. A longtime cannabis policy reform advocate, Jason first jumped into the cannabis economy as a graduate student while completing his master’s thesis, studying the legalization-land use-water policy nexus in Colorado. Jason recently delivered a presentation on this research, “Land Use, Water, and Policy Considerations in Emerging Cannabis Markets: Lessons from the Arid Mountain West” at the inaugural Institute for Cannabis Research conference at Colorado State University-Pueblo.
Cuomo advisor predicts New York will legalize pot in April
New York Governor Andrew Cuomo’s advisor on marijuana policy said this week the Empire State could legalize weed in April of next year with a bill that would serve as a model for other states looking to allow recreational pot in the United States.
Axel Bernabe, assistant counselor to Governor Cuomo, was a guest on the Under The Canopy series, recently launched by Canopy Growth, where he discussed cannabis legalization efforts in New York. According to Bernabe, a bill to legalize marijuana will be introduced through the state budget in January again, while he expects legalization to take effect by April.
As New Jersey appears ready to legalize marijuana this November, Bernabe said the Cuomo administration has been watching its neighbor “closely.”
“We’re watching New Jersey closely. We’ve always been confident that we’d get to this before New Jersey, so if they pass the referendum they still have to have an agreement between the governor and the Senate over there,” he said.
“If New Jersey can beat us to it, they’ll get a gold star but I still think we’re gonna set the model for this,” Bernabe added, referring to the bill’s social equity provisions, among other things.
During the interview, Bernabe also said that New York has been monitoring how legalization has been unfolding in Vermont, Maine, and Massachusetts, but has also consulted with states on the West Coast, where the legal pot industry is larger and more developed.
Regarding hemp, Cuomo’s advisor said the state will release its guidelines and regulations for CBD consumer products early next year as well.
“Those products are already out there, so there’s no sense in pretending they’re not,” Bernabe explained.
For this reason, the governor and his team have been working on guidelines, which will include maximum dose per serving labeling and warnings about potential THC content in various hemp-derived products. New York has copied a lot of Florida’s hemp regulations while crafting its own policies, Bernabe stated, before telling Canopy Growth’s David Culver that the administration is currently putting the finishing touches to the guidelines.
Although Governor Cuomo promised his state would legalize weed soon, marijuana legalization was left out of the New York state budget for 2020 due to the coronavirus pandemic, which hit the state particularly badly earlier this year.
Cuomo previously proposed working in conjunction with the neighboring states of New Jersey, Connecticut, and Pennsylvania on coordinating a recreational marijuana system for the region.
PURA Concludes Farmersville Meetings – Deal Imminent
Dallas, TX – October 20, 2020 – OTC PR WIRE — Puration, Inc. (OTC PINK: PURA) today announced that CEO Brian Shibley concluded a key meeting yesterday essential to finalizing the acquisition of 72-acre property in Farmersville, Texas central to the company’s recently announced Farmersville Brands strategy. “The acquisition is imminent. Look for an announcement very soon,” said Mr. Shibley.
PURA has scheduled the release of a comprehensive update this Friday, October 23, 2020, to provide the latest information on progress with the Farmersville Brand strategy. The Friday update this Friday will include the latest on the company’s planned dividend of PAO Group, Inc. (OTC PINK: PAOG) stock in conjunction with PURA’s sale of its cannabis cultivation business to PAOG.
For more information on Puration, visit http://www.purationinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Xinhua Silk Road: o setor solar da China deve concretizar um crescimento mais rápido em meio a um objetivo de neutralidade de carbono
Xinhua Silk Road: La industria solar de China adoptará un crecimiento más rápido en busca del objetivo de la neutralidad de carbono
jks: “I’m at the point in my career where I really just want to win a lot of things; this is the reason why I came to Complexity”
Insights on the Fermented Ingredients Global Market to 2027 – Strategic Recommendations for New Entrants
$6.9 Billion Worldwide Spandex Industry to 2027 – Impact of COVID-19 on the Market
Kimbell Royalty Partners Declares Third Quarter 2020 Distribution
Vitality edge out Astralis to reach DreamHack Open Fall grand final
$172 Million Worldwide Friction Stir Welding Equipment Industry to 2027 – Impact of COVID-19 on the Market
Three Verdant Power Tidal Turbines Deployed in New York City’s East River
Kennametal to Attend Baird 2020 Global Industrial Virtual Conference
MIBR add stand-in trio for BLAST Premier Fall, Flashpoint
Worldwide Thermal Energy Storage Industry to 2025 – Featuring Abengoa, Baltimore Aircoil & Brightsource Energy Among Others
Competition: Win Either Angry Birds VR or Acron: Attack of the Squirrels! for Oculus Quest
Complexity unveil jks
How Comodo’s Auto-Containment Technology Is Helping an IT Company Provide Ransomware Protection to Clients
Beat Saber Multiplayer for PlayStation VR Arrives Early 2021
The VR Game Launch Roundup: A Horrifyingly Tasty Selection
Microstrategy CEO Reveals BTC Purchase is Corporate Strategy to Adopt Bitcoin Standard
BOOBIE joins Yeah
EPRI Joins International Consortium to Overcome Barriers to Renewable Energy Integration
Global Boring Tools Industry (2020 to 2027) – Market Trajectory & Analytics
Betway Nine to Five 5 Swiss Stage Fantasy live with prizes
Antimicrobial Coatings Market Size is Anticipated To Reach USD 11.6 Billion By 2027 – Valuates Reports
Modular Uninterruptible Power Supply (UPS) Market worth $6.0 billion by 2025 – Exclusive Report by MarketsandMarkets™
HTC’s Cher Wang Given ‘Accenture VR Lifetime Achievement Award’ by AIXR
Global $3.4 Billion Aerosol Valves Market to 2027: Rise in Demand for Innovative Product Dispensing Technology & Product Differentiation
Taking LSD Could Help Your Career
Natus Vincere defeat Gambit to set up IEM New York CIS semi-final bout against Virtus.pro
Global $6.7 Billion Automated Storage & Retrieval Systems Market to 2025
Duke Energy announces dividend payments to shareholders
Lighting Control System Market Size is Projected to Reach USD 29990 Million by 2026 – Valuates Reports
Surge Energy America Recognized on Houston Business Journal’s Best Place to Work List
WAAREE spreads its wings globally, opens franchisee in Africa
Revuze, the first SaaS Consumer Insights eCommerce Platform
Create Games With Your Voice Inside the Anything World Beta
Bitcoin Price Bull Run Sees Grayscale Investments add $300M AUM in One Day
Blockchain Industry Leaders R3 and FORMS HK join Cyberport to Launch “Block AdVenture” Program
A senior BOJ official says the digital yen needs public support for it to become a reality.
PayPal May Buy Digital Asset Custodian BitGo Following Crypto Market Entry
Japanese soccer star Keisuke Honda launches his own crypto
Techcrunch6 days ago
Original Content podcast: It’s hard to resist the silliness of ‘Emily in Paris’
Startups6 days ago
Three views on the future of media startups
Startups6 days ago
Solve the ‘dead equity’ problem with a longer founder vesting schedule
Startups7 days ago
Pear hosted its invite-only demo day online this year; here’s what you might have missed
AI1 week ago
How AI Revolutionize the Way Video Games Developed and Played
Startups6 days ago
VCs reload ahead of the election as unicorns power ahead
Blockchain News1 week ago
Bitcoin Price to Reach $1 Million in 2025, Raoul Pal Adds One More Zero to His BTC Prediction
AR/VR1 week ago
‘Blaston’ is a Fantastically Creative VR ‘Shooter’ That’s All About Making You Move